The present invention relates to novel crystalline forms of the citrate salt of tegaserod, and to processes for the preparation of these novel crystalline forms. The invention also relates to pharmaceutical compositions containing these novel polymorphs, and to uses of said compositions to provide methods of treating patients suffering from gastrointestinal disorders.
申请公布号
WO2009053754(A3)
申请公布日期
2009.09.03
申请号
WO2008GB50992
申请日期
2008.10.24
申请人
GENERICS [UK] LIMITED;MYLAN DEVELOPMENT CENTRE PRIVATE LIMITED;GAITONDE, ABHAY;MANOJKUMAR, BINDU;BHALERAO, RAHUL;TANK, SINDERPAL;PADALKAR, VIKAS
